179 related articles for article (PubMed ID: 16148845)
1. Persistence of antibody to hepatitis B and protection from disease among Alaska natives immunized at birth.
Dentinger CM; McMahon BJ; Butler JC; Dunaway CE; Zanis CL; Bulkow LR; Bruden DL; Nainan OV; Khristova ML; Hennessy TW; Parkinson AJ
Pediatr Infect Dis J; 2005 Sep; 24(9):786-92. PubMed ID: 16148845
[TBL] [Abstract][Full Text] [Related]
2. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.
Bialek SR; Bower WA; Novak R; Helgenberger L; Auerbach SB; Williams IT; Bell BP
Pediatr Infect Dis J; 2008 Oct; 27(10):881-5. PubMed ID: 18756185
[TBL] [Abstract][Full Text] [Related]
3. Long-term persistence in protection and response to a hepatitis B vaccine booster among adolescents immunized in infancy in the western region of China.
Wang ZZ; Gao YH; Lu W; Jin CD; Zeng Y; Yan L; Ding F; Li T; Liu XE; Zhuang H
Hum Vaccin Immunother; 2017 Apr; 13(4):909-915. PubMed ID: 27874311
[TBL] [Abstract][Full Text] [Related]
4. Significance and anamnestic response in isolated hepatitis B core antibody-positive individuals 18 years after neonatal hepatitis B virus vaccination in Taiwan.
Su FH; Bai CH; Chu FY; Lin YS; Su CT; Yeh CC
Vaccine; 2012 Jun; 30(27):4034-9. PubMed ID: 22531558
[TBL] [Abstract][Full Text] [Related]
5. Antibody Levels and Protection After Hepatitis B Vaccine: Results of a 30-Year Follow-up Study and Response to a Booster Dose.
Bruce MG; Bruden D; Hurlburt D; Zanis C; Thompson G; Rea L; Toomey M; Townshend-Bulson L; Rudolph K; Bulkow L; Spradling PR; Baum R; Hennessy T; McMahon BJ
J Infect Dis; 2016 Jul; 214(1):16-22. PubMed ID: 26802139
[TBL] [Abstract][Full Text] [Related]
6. Long-term protection against hepatitis B after newborn vaccination: 20-year follow-up.
Roznovsky L; Orsagova I; Kloudova A; Tvrdik J; Kabieszova L; Lochman I; Mrazek J; Hozakova L; Zjevikova A; Pliskova L
Infection; 2010 Oct; 38(5):395-400. PubMed ID: 20589522
[TBL] [Abstract][Full Text] [Related]
7. Presence of immune memory and immunity to hepatitis B virus in adults after neonatal hepatitis B vaccination.
Zhu CL; Liu P; Chen T; Ni Z; Lu LL; Huang F; Lu J; Sun Z; Qu C
Vaccine; 2011 Oct; 29(44):7835-41. PubMed ID: 21816197
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of recombinant hepatitis B vaccine: comparison of two different vaccination schedules.
Agladioglu S; Beyazova U; Camurdan AD; Sahin F; Atak A
Infection; 2010 Aug; 38(4):269-73. PubMed ID: 20512395
[TBL] [Abstract][Full Text] [Related]
9. Implementation of hepatitis B vaccine in high-risk young adults with waning immunity.
Posuwan N; Vorayingyong A; Jaroonvanichkul V; Wasitthankasem R; Wanlapakorn N; Vongpunsawad S; Poovorawan Y
PLoS One; 2018; 13(8):e0202637. PubMed ID: 30125298
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B immunity and response to booster vaccination in children with inflammatory bowel disease treated with infliximab.
Moses J; Alkhouri N; Shannon A; Raig K; Lopez R; Danziger-Isakov L; Feldstein AE; Zein NN; Wyllie R; Carter-Kent C
Am J Gastroenterol; 2012 Jan; 107(1):133-8. PubMed ID: 21876562
[TBL] [Abstract][Full Text] [Related]
11. Intradermal vaccination of adults with three low doses (2 micrograms) of recombinant hepatitis B vaccine. II. Persistence of immunity and induction of immunologic memory.
Elisbão Mdo C; Baldy JL; Bonametti AM; Reiche EM; Morimoto HK; Pontello R; Matsuo T; Ferelle A; Neves J
Mem Inst Oswaldo Cruz; 2003 Dec; 98(8):1109-13. PubMed ID: 15049099
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years.
Hammitt LL; Hennessy TW; Fiore AE; Zanis C; Hummel KB; Dunaway E; Bulkow L; McMahon BJ
Vaccine; 2007 Sep; 25(39-40):6958-64. PubMed ID: 17714836
[TBL] [Abstract][Full Text] [Related]
13. Antibody levels and protection after hepatitis B vaccination: results of a 15-year follow-up.
McMahon BJ; Bruden DL; Petersen KM; Bulkow LR; Parkinson AJ; Nainan O; Khristova M; Zanis C; Peters H; Margolis HS
Ann Intern Med; 2005 Mar; 142(5):333-41. PubMed ID: 15738452
[TBL] [Abstract][Full Text] [Related]
14. The Serum Anti-HBs Level Among Children Who Received Routine Hepatitis B Vaccination During Infancy in Mianyang City, China: A Cross-Sectional Study.
He F; Ma YJ; Zhou TY; Duan JC; Wang JF; Ji YL; Li H; Zhang JY; Tang H
Viral Immunol; 2016; 29(1):40-8. PubMed ID: 26565951
[TBL] [Abstract][Full Text] [Related]
15. Persistence of anti-HBs antibody and immunological memory in children vaccinated with hepatitis B vaccine at birth.
Jafarzadeh A; Montazerifar SJ
J Ayub Med Coll Abbottabad; 2006; 18(4):4-9. PubMed ID: 17591001
[TBL] [Abstract][Full Text] [Related]
16. Long-term anti-HBs antibody persistence following infant vaccination against hepatitis B and evaluation of anamnestic response: a 20-year follow-up study in Thailand.
Poovorawan Y; Chongsrisawat V; Theamboonlers A; Crasta PD; Messier M; Hardt K
Hum Vaccin Immunother; 2013 Aug; 9(8):1679-84. PubMed ID: 23732904
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus exposure during childhood in Cameroon, Central African Republic and Senegal after the integration of HBV vaccine in the expanded program on immunization.
Rey-Cuille MA; Njouom R; Bekondi C; Seck A; Gody C; Bata P; Garin B; Maylin S; Chartier L; Simon F; Vray M
Pediatr Infect Dis J; 2013 Oct; 32(10):1110-5. PubMed ID: 23694839
[TBL] [Abstract][Full Text] [Related]
18. Comparative long term immunogenicity of two recombinant hepatitis B vaccines and the effect of a booster dose given after five years in a low endemicity country.
Duval B; Gîlca V; Boulianne N; De Wals P; Massé R; Trudeau G; De Serres G
Pediatr Infect Dis J; 2005 Mar; 24(3):213-8. PubMed ID: 15750456
[TBL] [Abstract][Full Text] [Related]
19. Waning-off effect of serum hepatitis B surface antibody amongst Taiwanese university students: 18 years post-implementation of Taiwan's national hepatitis B vaccination programme.
Su FH; Chen JD; Cheng SH; Sung KY; Jeng JJ; Chu FY
J Viral Hepat; 2008 Jan; 15(1):14-9. PubMed ID: 18088240
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus antibody levels 7 to 9 years after booster vaccination in Alaska native persons.
Keck JW; Bulkow LR; Raczniak GA; Negus SE; Zanis CL; Bruce MG; Spradling PR; Teshale EH; McMahon BJ
Clin Vaccine Immunol; 2014 Sep; 21(9):1339-42. PubMed ID: 25056363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
